The Alliance for Reg
The Alliance for Regenerative Medicine Releases Q1 2018 Data Report, Highlighting Sector Trends and Metrics
10 mai 2018 09h26 HE | Alliance for Regenerative Medicine
WASHINGTON, D.C., May 10, 2018 (GLOBE NEWSWIRE) --  The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly data report, offering an in-depth look at cell therapy, gene...
ADVERUM_ID_RGB 200x49.jpg
Adverum Biotechnologies Announces Leadership Changes
03 mai 2018 16h30 HE | Adverum Biotechnologies, Inc.
MENLO PARK, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Presentations at the Upcoming Annual Meeting of The American Society of Gene and Cell Therapy (ASGCT)
30 avr. 2018 12h00 HE | uniQure Inc.
New Data Further Demonstrating Favorable Immunogenicity Profile of AAV5 to be Featured in Oral Presentation LEXINGTON, Mass. and AMSTERDAM, The Netherlands, April 30, 2018 (GLOBE NEWSWIRE) --...
Alliance Reg Med.png
The Alliance for Regenerative Medicine Releases Complete Agenda for Sixth Annual Cell & Gene Therapy Investor Day
28 mars 2018 10h47 HE | Alliance for Regenerative Medicine
WASHINGTON, DC, March 28, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today released the complete agenda for its upcoming sixth annual Cell & Gene Therapy Investor Day,...
PacBio logo.jpg
Study Demonstrates Potential for SMRT Sequencing to Improve the Safety of Gene Therapy Protocols
15 mars 2018 07h30 HE | Pacific Biosciences, Inc.
MENLO PARK, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- A new publication in the journal of the American Society of Gene & Cell Therapy demonstrates the utility of Single Molecule, Real-Time...
Voyager_Logos_Square_Logo_Light.png
Voyager Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
14 mars 2018 07h02 HE | Voyager Therapeutics, Inc.
VY-AADC for advanced Parkinson’s disease on track for start of planned global, pivotal Phase 2-3 program during the middle of this year Two IND filings expected from the ALS, Huntington’s disease and...
Adverum_Primary_Medium.png
Adverum Biotechnologies Reports Fourth Quarter 2017 Financial Results and Provides Corporate Update
06 mars 2018 16h00 HE | Adverum Biotechnologies, Inc.
MENLO PARK, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular...
Alliance Reg Med.png
The Alliance for Regenerative Medicine Releases 2017 Annual Data Report, Highlighting Sector Trends and Metrics
05 mars 2018 10h43 HE | Alliance for Regenerative Medicine
WASHINGTON, D.C., March 05, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today announced the release of its 2017 Annual Data Report, offering an in-depth look at trends and...
The Global Gene Ther
The Global Gene Therapy Market is forecast to hit $363 million by 2022
05 mars 2018 02h56 HE | Market Reports Center
NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- A new study “Global Gene Therapy Market Analysis & Forecast to 2022” forecast global gene therapy market is forecast to hit $363 million by 2022. A...
ibn.png
NetworkNewsWire Announces Publication on Exciting Treatment Advancements Through Gene Therapy
01 mars 2018 08h30 HE | NetworkNewsWire
NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial...